Literature DB >> 28120102

Erratum to: Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.

Toshiyuki Yoneda1,2, Hiroshi Hagino3,4, Toshitsugu Sugimoto5,4, Hiroaki Ohta6,7, Shunji Takahashi8,4, Satoshi Soen9,7, Akira Taguchi10,11, Toshihiko Nagata12,13, Masahiro Urade14,15, Takahiko Shibahara16,15, Satoru Toyosawa17,18.   

Abstract

Entities:  

Year:  2017        PMID： 28120102     DOI： 10.1007/s00774-017-0816-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN： 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  3 in total

Review 1.  Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.

Authors:  Takahiko Shibahara
Journal:  Jpn Dent Sci Rev       Date:  2019-03-18

2.  Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database.

Authors:  Ayaka Inada; Keiko Hosohata; Saki Oyama; Iku Niinomi; Yasuhiro Mori; Yuki Yamaguchi; Mayako Uchida; Kazunori Iwanaga
Journal:  Ther Clin Risk Manag       Date:  2018-12-24       Impact factor: 2.423

3.  Allogeneic multipotent mesenchymal stromal cell sheet transplantation promotes healthy healing of wounds caused by zoledronate and dexamethasone in canine mandibular bones.

Authors:  Nobuyuki Kaibuchi; Takanori Iwata; Satoru Onizuka; Kosei Yano; Yuka Tsumanuma; Masayuki Yamato; Teruo Okano; Tomohiro Ando
Journal:  Regen Ther       Date:  2019-01-12       Impact factor: 3.419
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.